- Identify what biomarkers should be utilized to detect the most at-risk population, to detect the disease while measurable and yet not clinically apparent?
- identify the most relevant candidate biomarkers of early detection in Thoracic Cancers
- Describe critical aspects of study design in molecular biomarkers for early detection of lung cancer
Tuesday, February 21, 2017 - 6:45am to 7:45am
Jussuf Kaifi, MD, PhD
Chicago, IL 60637
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation